Literature DB >> 14664757

Neurologic paraneoplastic syndromes.

Edward J Dropcho1.   

Abstract

Paraneoplastic disorders can affect any part of the central or peripheral nervous system. Although relatively uncommon, these disorders are a significant cause of severe neurologic disability among cancer patients. Many paraneoplastic disorders are believed to be caused by an autoimmune response directed against shared neural tumor antigens. This article summarizes the clinical features, possible autoimmune pathophysiology, and management issues for patients with paraneoplastic disorders.

Entities:  

Mesh:

Year:  2004        PMID: 14664757     DOI: 10.1007/s11912-996-0006-8

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  48 in total

1.  Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

Authors:  F Graus; F Keime-Guibert; R Reñe; B Benyahia; T Ribalta; C Ascaso; G Escaramis; J Y Delattre
Journal:  Brain       Date:  2001-06       Impact factor: 13.501

2.  Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome.

Authors:  W P Mason; F Graus; B Lang; J Honnorat; J Y Delattre; F Valldeoriola; J C Antoine; M K Rosenblum; M R Rosenfeld; J Newsom-Davis; J B Posner; J Dalmau
Journal:  Brain       Date:  1997-08       Impact factor: 13.501

3.  Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus.

Authors:  L Bataller; F Graus; A Saiz; J J Vilchez
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

4.  Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics.

Authors:  H R Lee; V A Lennon; M Camilleri; C M Prather
Journal:  Am J Gastroenterol       Date:  2001-02       Impact factor: 10.864

Review 5.  Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.

Authors:  J L Keltner; C E Thirkill; P T Yip
Journal:  J Neuroophthalmol       Date:  2001-09       Impact factor: 3.042

6.  Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders.

Authors:  F Blaes; M Strittmatter; S Merkelbach; V Jost; M Klotz; K Schimrigk; G F Hamann
Journal:  J Neurol       Date:  1999-04       Impact factor: 4.849

7.  Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies.

Authors:  J C Antoine; J F Mosnier; L Absi; P Convers; J Honnorat; D Michel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

8.  CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity.

Authors:  Z Yu; T J Kryzer; G E Griesmann; K Kim; E E Benarroch; V A Lennon
Journal:  Ann Neurol       Date:  2001-02       Impact factor: 10.422

9.  Mechanisms of photoreceptor cell death in cancer-associated retinopathy.

Authors:  T Maeda; A Maeda; I Maruyama; K I Ogawa ; Y Kuroki; H Sahara; N Sato; H Ohguro
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-03       Impact factor: 4.799

10.  Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

Authors:  E Rudnick; Y Khakoo; N L Antunes; R C Seeger; G M Brodeur; H Shimada; R B Gerbing; D O Stram; K K Matthay
Journal:  Med Pediatr Oncol       Date:  2001-06
View more
  1 in total

1.  The case of a 30-year-old man with subacute gait instability, weakness, and muscle spasms.

Authors:  Mitesh P Mehta; Leonard L Sokol
Journal:  Ann Clin Transl Neurol       Date:  2020-11-11       Impact factor: 5.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.